In a significant breakthrough for cancer immunotherapy, collaborative studies published simultaneously in Immunity & ...

Immune Checkpoint Blockade (ICB) has revolutionized the treatment of cancers like melanoma, but up to 60% of patients don't respond to this immunotherapy for reasons not yet fully understood.

RA patients on upadacitinib and methotrexate showed robust antibody and T-cell responses to the recombinant zoster vaccine over 60 weeks. The vaccine maintained a satisfactory humoral response in 71.4 ...

Progressive multifocal leukoencephalopathy (PML) is a rare but serious brain infection. It gradually destroys brain tissue ...

Our NAV-005 antagonist binds the immunosuppressive HIO-1 factor and blocks its ability to suppress mAb, TCE and ADC ...

A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.

A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new mechanism showing ...

Predicting how circulating immune cells interact with human tissues remains a major challenge in preclinical drug testing. Traditional static culture ...

TRex Bio banked a Series B extension to advance its atopic dermatitis program, which is competing in a crowded field.

Oranges aren’t the only immune-supporting food. Red bell peppers, spinach, papaya, and ginger also provide key nutrients for ...